Open access and available facilities
The Tres Cantos site in Spain is home to GSK DDW specialist research facility, which is focused on discovering and developing new medicines for Diseases of the Developing World.
More than 100 scientific staff work at the campus in a range of areas including medicinal chemistry, parasitology, mycobacteriology, pharmacology and toxicology.
The combination of these facilities and expertise enables this Tres Cantos centre to take care of all scientific needs of drug discovery and development from screening campaigns to clinical Proof of Concept studies (Phase IIb).
This site is also home to the Open Lab, which is integrated within the facilitys Discovery Performance Units focused on Malaria, TB, Kinetoplastids and Shigella.
Visiting scientists to the Open Lab often cite access to world-class facilities and the opportunity to work with scientists who work in the drug discovery field as the key benefits of the Open Lab's unique approach.
The Open Lab gives visiting scientists access to GSK drug discovery, pre-clinical expertise, capabilities and the benefits of working as part of a project team.
This bold and flexible approach has positioned the Open Lab as a dynamic research hub for diseases of the developing world, helping to stimulate innovative research that could ultimately result in the discovery and development of new medicines.
The Open Lab provides access to:
⇛ Medicinal Chemistry (organic synthesis without access to natural product facilities)
⇛NMR spectroscopy and LC/MS spectrometry
⇛Pharmacology (in vitro DMPK and preliminary toxicology)
⇛Biochemistry and Molecular Biology
The combination of these facilities and expertise enables GSK DDW to take care of all scientific phases of drug discovery and development from screening campaigns to clinical Proof of Concept studies. (Phase IIb)